Telix Pharmaceuticals (TLX) director discloses 3,719 Ordinary Shares

Rhea-AI Filing Summary

Telix Pharmaceuticals Ltd director Marie Elizabeth McDonald has filed an initial ownership report on Form 3. The filing shows an indirect holding of 3,719 Ordinary Shares held through Netwealth Investments Limited as custodian. This is a disclosure of existing holdings rather than a new share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McDonald Marie Elizabeth

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Ordinary Shares — 3,719 shares (Indirect, Netwealth Investments Limited)

Footnotes (1)

1. [object Object]

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McDonald Marie Elizabeth

(Last) (First) (Middle)

C/O TELIX PHARMACEUTICALS LTD

55 FLEMINGTON RD

(Street)

NORTH MELBOURNE 3051

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Telix Pharmaceuticals Ltd [ TLX ]

3a. Foreign Trading Symbol
[TLX]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,719	I	Netwealth Investments Limited(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Custodian for ordinary shares reported as indirectly held by Ms. McDonald.

Remarks:

Ex. 24 - Power of Attorney

	/s/ Genevieve Ryan, on behalf of Ms. Marie McDonald	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Telix Pharmaceuticals (TLX) Form 3 filing show for Marie Elizabeth McDonald?

The Form 3 shows director Marie Elizabeth McDonald indirectly holding 3,719 Telix Pharmaceuticals Ordinary Shares. These shares are reported as existing ownership and provide a baseline of her equity stake at the time of becoming a reporting insider.

How many Telix Pharmaceuticals (TLX) shares does Marie Elizabeth McDonald hold?

Marie Elizabeth McDonald is reported as indirectly holding 3,719 Ordinary Shares of Telix Pharmaceuticals. This position reflects her beneficial ownership as disclosed in the Form 3 and establishes her initial reported stake as a company director.

Are Marie Elizabeth McDonald’s Telix (TLX) shares held directly or indirectly?

Her 3,719 Telix Pharmaceuticals Ordinary Shares are held indirectly. The filing identifies Netwealth Investments Limited as the custodian, meaning the shares are registered under that entity while still being attributed to her for reporting purposes.

Does the Telix (TLX) Form 3 for Marie Elizabeth McDonald report any recent share transactions?

The Form 3 does not report any buy or sell transactions; it classifies the entry as a holding. It simply records that she beneficially owns 3,719 Ordinary Shares, providing an initial snapshot of her equity position as a director.

Who is listed as custodian for Marie Elizabeth McDonald’s Telix (TLX) shares?

Netwealth Investments Limited is listed as custodian for the Ordinary Shares reported as indirectly held by Marie Elizabeth McDonald. This means Netwealth holds the shares on her behalf, while she remains the beneficial owner for disclosure purposes.